Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...
Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...
The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...
Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long term survivors (>=2 years) from ...
A brain protein called ANO2 has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections and MS ...
OS Therapies releases trial data supporting FDA approval, U.K. and U.S. timelines, and potential eligibility for a valuable ...
Inflammation is a vascular or blood vessel and cellular reaction in the human body to stimulus and trauma. It refers to your body's process of fighting against things that harm it, such as infections, ...
The surprising new research behind what actually causes high blood pressure – and the best ways to keep yours in check ...
Scientists at the University of the Western Cape say they have developed a low-cost, highly sensitive and rapid screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback